TULANE UNIVERSITY
Clinical Trials
99
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (81 trials with phase data)• Click on a phase to view related trials
Continuous Glucose Monitoring (CGM) in an Underserved Population
- Conditions
- DiabetesDiabetes MellitusDiabetes Type 2
- First Posted Date
- 2025-08-22
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 50
- Registration Number
- NCT07135531
- Locations
- 🇺🇸
University Medical Center, New Orleans, Louisiana, United States
VR Mindfulness for People With HIV and Substance Use
- Conditions
- HIVSubstance Use (Drugs, Alcohol)
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 30
- Registration Number
- NCT07088289
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
- Conditions
- Hidradenitis Suppurativa
- Interventions
- Drug: Topical roflumilast 0.3% foam
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 10
- Registration Number
- NCT07077902
- Locations
- 🇺🇸
Lakeview Hospital, Covington, Louisiana, United States
🇺🇸Lakeside Hospital, New Orleans, Louisiana, United States
🇺🇸LCMC Multi-speciality Clinic, New Orleans, Louisiana, United States
Enhancing Diabetes Care by Treating Insomnia
- Conditions
- Diabetes Type 2Insomnia
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 30
- Registration Number
- NCT07062406
- Locations
- 🇺🇸
Southeast Community Health Systems, Zachary, Louisiana, United States
The Cooking for Health Optimization and Disease Prevention (CHOP) Trial
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 96
- Registration Number
- NCT07011459
- Locations
- 🇺🇸
The Goldring Center for Culinary Medicine, New Orleans, Louisiana, United States
🇺🇸Tulane Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
Answer ALS Launches AI-Powered Drug Discovery Initiative to Accelerate ALS Treatment Development
Answer ALS has launched LADDIA, a groundbreaking AI-powered drug discovery collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane University to accelerate ALS treatment development.
Morning Coffee Consumption Linked to Reduced Cardiovascular Death Risk and Healthy Aging in Women
New research published in the European Heart Journal shows that consuming coffee exclusively in the morning reduces premature death risk by 16% and cardiovascular death risk by 31% compared to non-coffee drinkers.
Novel Senolytic Drug Shows Promise for MASLD and Liver Cancer Treatment
Researchers from UT Health San Antonio and Tulane University have developed a new drug candidate that effectively eliminates senescent "zombie cells" from the liver, showing potential for treating MASLD and liver cancer.